
Gauging the Accuracy of Laboratory Testing From Medicare Data-Reply
James W. Winkelman, MD
Brigham and Women's Hospital Boston, Mass
Stephen T. Mennemeyer, PhD
University of Alabama at Birmingham
JAMA. 1993;269(23):2985-2986.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
In Reply.
—In our article we made one fundamental point: health insurance claims data can be fruitfully used to track patient outcomes and to screen for laboratories that are having a higher than expected frequency of bad outcomes. We illustrated this use of claims data by examining Medicare patient outcomes following outpatient PT testing. We found that risks for stroke and myocardial infarction were higher when patients had been tested in low-volume physician office laboratories, when the site of testing switched between successive tests, and when the patient had no history of testing in the prior 6 months. We also found that patients in states with stronger regulatory climates had lower risk for stroke; similar results for myocardial infarction were not statistically significant.
According to our approach with a large database of laboratories and clinicians, all factors that lead to adverse outcomes that are attributable to physicians' activities once the
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|